NIAGEN BIOSCIENCE, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
NIAGEN BIOSCIENCE, INC. (NAGE) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$3.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-04
- NIAGEN BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$3.80M.
- NIAGEN BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was -$2.10M, a 2200.00% decline from fiscal 2023.
- NIAGEN BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $100.00K, a 96.55% decline from fiscal 2022.
- NIAGEN BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $2.90M, a 64.20% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | -$3.80M 10-K · filed 2026-03-04 |
| 2024-12-31 | -$2.10M 10-K · filed 2025-03-04 |
| 2023-12-31 | $100.00K 10-K · filed 2024-03-06 |
| 2022-12-31 | $2.90M 10-K · filed 2023-03-08 |
| 2021-12-31 | $8.10M 10-K · filed 2022-03-14 |
| 2013-12-28 | $1.73M 10-K · filed 2014-03-27 |
| 2012-12-29 | $4.14M 10-K · filed 2014-03-27 |
| 2011-12-31 | $2.95M 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |